Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT04378114

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04378114
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04378114. Non-randomized; no masking; primary purpose other. Start 2020-05-18 (actual); primary completion 2020-07-17 (actual). Results posted on 2023-09-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults
Condition
Type 1 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. C sensor algorithm applied retrospectively to raw sensor data.
Intervention (Device)
Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter. Zeus sensor algorithm applied retrospectively to raw sensor data.
Intervention (Drug)
Acetominophen
Lead sponsor
Medtronic MiniMed, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04378114
Content hash
492731254d5469b0133619b4070b431b67e7310c145a3a67604ebbc2d5e54405